To measure changes in nuclear gene expression resulting from mitochondrial dysfunction in retinal pigment epithelial cells. METHODS. ARPE-19 retinal pigment epithelial cells were depleted of their mitochondrial (mt)DNA by passaging in a low concentration of ethidium bromide. Loss of mitochondrial DNA was determined by uridine auxotrophy and quantitative real-time polymerase chain reaction of isolated DNA. Loss of mitochondrial membrane potential was estimated by uptake of JC-1. Changes in nuclear gene expression were determined by quantitative real-time reverse transcription-polymerase chain reaction of isolated total RNA from ethidium-bromide-treated and untreated cells. Morphologic and phenotypic changes were determined by phase-contrast microscopy, sensitivity to the oxidant tert-butyl hydroperoxide (tBH), and invasion assay. RESULTS. ARPE-19 cells became auxotrophic for growth on uridine after eight passages in 50 ng/mL ethidium bromide. Quantitative PCR revealed almost complete loss of mitochondrial DNA ( 0 cells). Uptake of JC-1 was reduced in the 0 cells, indicating reduction of mitochondrial membrane potential. Quantitative RT-PCR measured increased expression of genes coding for drusen components, lipid transport, extracellular matrix components, and responses to inflammation in the 0 cells. The 0 cells also exhibited an increased sensitivity to killing by tBH and increased migration and invasion through solubulized basement membrane-coated tissue culture inserts. CONCLUSIONS. ARPE-19 cells respond to loss of mitochondrial function by changes in nuclear gene expression that resemble changes observed in age-related macular degeneration. The results lead to the hypothesis that loss of mitochondrial function with age and resultant changes in nuclear gene expression may explain some of the changes in the macula that are associated with the known clinical manifestations of age-related macular degeneration. (Invest Ophthalmol Vis Sci. 2005; 46:1765-1773) DOI:10.1167/iovs.04-1327 T he retinal pigment epithelium (RPE) is a single layer of cells in the vertebrate retina, and its continuous function has been shown to be necessary for vision.
cells. The 0 cells also exhibited an increased sensitivity to killing by tBH and increased migration and invasion through solubulized basement membrane-coated tissue culture inserts. CONCLUSIONS. ARPE-19 cells respond to loss of mitochondrial function by changes in nuclear gene expression that resemble changes observed in age-related macular degeneration. The results lead to the hypothesis that loss of mitochondrial function with age and resultant changes in nuclear gene expression may explain some of the changes in the macula that are associated with the known clinical manifestations of age-related macular degeneration. ( T he retinal pigment epithelium (RPE) is a single layer of cells in the vertebrate retina, and its continuous function has been shown to be necessary for vision. 1, 2 The RPE is a terminally differentiated tissue that ages in a unique fashion and in which changes with age have been implicated in the development of age-related macular degeneration (AMD), 3, 4 the leading cause of untreatable vision loss in persons older than 65 years in developed countries. 5, 6 Indeed, it has been estimated that at least 8 million people Ն65 years of age in the United States are at high risk for the development of advanced AMD. 7 Some of the changes that have been shown to occur in the macula and that correlate with AMD include increased deposition in the RPE of the age pigment lipofuscin, 8, 9 the development of drusen between the RPE basal lamina and Bruch's membrane, 10, 11 increased sterol deposition in the elastin layer of Bruch's membrane, 12 thickening of Bruch's membrane and other basement membrane changes, 13, 14 choroidal neovascularization, 15, 16 and RPE cell apoptosis. 17 Although the clinical manifestations of RPE aging are well described and several theories have been proposed to explain the cause of AMD, none of these theories has led to a satisfactory understanding of this unique aging phenotype.
We have been working to understand how changes in mitochondrial function contribute to aging phenotypes in eukaryotic cells. In one model of eukaryotic mitochondrial dysfunction, yeast cells that have been depleted of their mitochondrial (mt)DNA ( 0 cells) respond to loss of mitochondrial function with induction of a specific pathway that induces changes in nuclear gene expression. 18 These changes, called retrograde regulation or retrograde response, respond to this loss in a way that not only compensates for the loss of respiratory function but also results in increased replicative lifespan in cells grown on fermentable substrates. 19, 20 Furthermore, our laboratory has demonstrated that mitochondrial dysfunction is a normal consequence of yeast aging and that the retrograde response increases with replicative age and titrates the progressive loss of mitochondrial function to enhance longevity. 21 Mammalian cells also respond to loss of mitochondrial function with changes in nuclear gene expression. It has been shown that the mitochondrial-to-nuclear stress signal is probably due to a decrease in mitochondrial membrane potential, which results in increased cytosolic free [Ca] 2ϩ . 22 The increased in [Ca] 2ϩ in turn activates Ca 2ϩ -sensitive protein phosphatases, kinases, and calcium-calmodulin kinase IV (CaMKIV), which activate transcription factors, resulting in changes in nuclear gene expression. 23 Although these changes in nuclear gene expression seem to be necessary for cell survival, we have shown that the specific genes induced are common to several cell types or are cell-type specific and appear to be dependent on the differentiated functions of the cell. 24 In this study, we attempted to establish a link between the loss of mitochondrial function in RPE cells and changes that contribute to the development of AMD, by investigating changes in nuclear gene expression in ARPE-19 cells brought on by loss of mtDNA ( 0 ARPE-19). These cells contain mitochondria but cannot respire, because of the absence of the subset of 13 respiratory transport chain proteins that are coded for by the mitochondria. We have previously reported that 0 ARPE-19 cells induce the transcription of glycolytic pathway genes to maintain energy production, genes to maintain cellular redox potential and mitochondrial membrane potential, and genes that may allow for increased stress resistance and protect the cell against cell death. 24 Furthermore, there is evidence in the literature that a reduction in mitochondrial function may contribute to the development of AMD. 25, 26 Therefore, we hypothesized that changes in RPE nuclear gene expression due to loss of mitochondrial function may help explain some of the phenotypic changes in aged RPE cells that lead to the clinical manifestations in AMD. In this study, we more thoroughly characterized 0 ARPE-19 cells as a model system in which to study loss of mitochondrial function and demonstrate some specific changes in nuclear gene expression and in cell phenotype due to mitochondrial dysfunction.
MATERIALS AND METHODS

Cell Culture
The retinal pigment epithelial cell line ARPE-19 was obtained from ATCC (Manassas, VA). ARPE-19 is an established cell line that has been shown to express many of the characteristics of RPE cells in culture. 27 The cells were grown in DMEM/Ham's F12 1:1 (Invitrogen-Gibco, Grand Island, NY) containing 24 mM sodium bicarbonate, 10% FBS, 10 g/mL uridine, and 1.0 mM sodium pyruvate. All cells were maintained in a 5% CO 2 humidified atmosphere at 37°C and grown without added antibiotics or fungicides.
The ARPE-19 cells were depleted of their mtDNA with ethidium bromide (EtBr). 28 ARPE-19 cells were grown in T75 flasks and then passaged 1:3 into medium containing 50 ng/mL EtBr. Cells were grown until confluent and then serially passaged in medium containing EtBr.
The cells were screened for loss of mtDNA by passaging into medium without added uridine containing 10% dialyzed FBS. Cells that have lost their mtDNA become auxotrophic for growth on uridine due to the loss of functional dihydroorotate dehydrogenase, which is located on the outer surface of the mitochondrial inner membrane. After five to seven passages, the ARPE-19 cells were unable to grow without added uridine. Loss of the mitochondrial genome was confirmed by quantitative real-time polymerase chain reaction (PCR), with a primer set that spanned the origin of replication of the mitochondrial heavy strand, as described later. Control cells were treated in an identical fashion, except that EtBr was omitted from the medium.
Nucleic Acid Isolation and Quantitative Real-Time RT-PCR
DNA and RNA were isolated from trypsinized cells with isolation kits (DNeasy or RNeasy; Qiagen, Valencia, CA). RNA was isolated with on-column DNase I digestion from recently confluent cells that had been fed 6 hours earlier. Final yields and concentrations were calculated by measuring the absorbance at 260 nm in 10 mM Tris, 1 mM EDTA (pH 7.5; TE buffer).
The genes of interest were chosen because their protein products have been identified as components of drusen, because they have been shown to be upregulated in RPE or retina of individuals with AMD, because of their association with extracellular components of Bruch's membrane, or because of their association with outer segment phagocytosis or lipid transport into the RPE. Table 1 is a list of the genes analyzed and their descriptions.
Real-time quantitative RT-PCR was performed on a commercial system (Prism 7000 Sequence Detection real-time PCR system; Applied Biosystems, Inc.
[ABI], Foster City, CA) in a two-step reaction. Total 
Estimation of Mitochondrial Membrane Potential
ARPE-19 cells were plated on two-well chamber slides (InterMed, Naperville, IL) and grown until confluent. The cells were incubated with 10 nM of the lipophilic dye JC-1 in complete medium for 10 minutes at 37°C, 29 and either rinsed with PBS, coverslipped, and observed under a fluorescence microscope or trypsinized and analyzed in a flow cytometer. For microscopy the cells were observed by deconvolution microscope equipped with a mercury lamp and filters for epifluorescence applications (model DMRXA; Leica, Deerfield, IL). Digital images were then obtained (Sensicam QE 12-bit, cooled CCD system; PCO AG, Kelheim, Germany; and SlideBook image-processing software; Intelligent Imaging Innovations, Santa Monica, CA). Alternatively, the cells were analyzed with a flow cytometer (EPICS; Beckman Coulter, Inc., Fullerton, CA) and the data collected in both the FITC and rhodamine channels.
Cell Viability MTT Assay
Cell viability after oxidative stress was assessed with 3-(4,5-dimethylthiazol-2,5-diphenyl tetrazolium bromide (MTT). Cells plated in 24-well plates were grown to confluence and treated with 0 to 2000 M tert-butyl hydroperoxide (tBH), for 6 hours in the absence of serum. After treatment, the cells were fed with growth medium and maintained overnight. The next day, the cells were incubated with DMEM without phenol red, containing 5% FBS and 1.0 mM MTT for 2 hours at 37°. Afterward, the cells and the formazan MTT reduction product were solubilized with 0.1 g/mL SDS in 0.01 M HCl and read at 570 nm.
Cell Invasion Assay
Cell invasion assays were performed in growth-factor-reduced, solubulized basement membrane (Matrigel)-coated, 24-well invasion cham- 
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bers (BD Biosciences, Franklin Lakes, NJ). The precoated wells were rehydrated by incubation with 500 L of culture medium in the lower chamber, and then 5 ϫ 10 4 cells in 300 L of medium were added to the upper chamber. The wells were incubated at 37°C for 48 hours under normal culture conditions. The medium was removed, and the cells adhering to the upper side of the membrane were removed by scrubbing three times with a cotton swab moistened with culture medium. The cells remaining on the underside of the membrane were then fixed with 0.5 mL 2% formaldehyde and 0.2% glutaraldehyde in PBS for 10 minutes. After they were rinsed, the cells were stained with 0.5 mL hematoxylin, counterstained with eosin, and rinsed with distilled water. The number of cells that migrated to the underside of the membrane was determined with an inverted microscope. In all, the assay was performed in duplicate two times, and three fields per insert were counted and averaged.
Statistical Analysis
Testing of statistical significance was performed on computer (StatMost; DataMost Corp., Sandy, UT). For the real-time RT-PCR data, Student's paired t-test was performed on the raw values corrected for DNA loading as described earlier. P Յ 0.05 was taken as the criterion of significance.
RESULTS
The EtBr treatment of ARPE-19 cells resulted in a morphologic change in the cells and an almost complete loss of the mtDNA. Figure 1A shows photomicrographs of ARPE-19 cells ( ϩ ) and ARPE-19 cells that had been treated with EtBr for eight passages ( 0 ). In general 0 ARPE-19 cells grew more slowly, were unable to grow without added uridine, and appeared to spread out more. Partial characterization of the 0 ARPE-19 cells has been reported. 24 Figure 1B shows an amplification plot of a real-time quantitative PCR analysis of DNA isolated from ϩ ARPE-19 and 0 ARPE-19 cells. The primers were chosen to amplify a region of the mtDNA that spans the origin of replication of the mtDNA heavy strand. Quantitative PCR showed mtDNA at Ͻ2.5 ϫ 10 Ϫ4 that of control cells. We estimated mitochondrial membrane potential in the 0 ARPE-19 cells by using the lipophilic cationic fluorescent probe JC-1. Transport of JC-1 into mitochondria has been shown to be dependent on the mitochondrial membrane potential, and the fluorescence of JC-1 has been shown to change from green to red due to the formation of J aggregates at higher membrane potentials. Figure 2 shows fluorescence microscope images of ϩ ARPE-19 and 0 ARPE-19 cells that were treated with JC-1. The micrographs demonstrate that the 0 ARPE-19 cells had reduced uptake of the dye, which indicates a lower mitochondrial membrane potential than in the untreated ϩ ARPE-19 cells. This result was confirmed by flow cytometry.
When we measured changes in nuclear gene expression resulting from loss of mitochondrial function in a select set of genes, the results were dramatic. We arranged this select set of genes in four groups, and the results are shown in Figure 3 (see Table 1 for accepted gene names). Group 3B contained genes that code for components of the extracellular matrix. We measured a large increase in expression of COL1A1, COL5A1, MMP2, and PLAU; modest increased expression of PLAUR and LOX; and decreased expression of TIMP3.
Group 3C contained genes associated with lipid transport in the RPE. We noted a large increase in APOE expression, and increased expression of VLDLR, SCARB1, SCARB2, and CD68.
Group 3D contained genes associated with a response to inflammation or oxidative stress. We noted a large increase in expression of VEGF and increases in TGFB1, FGF5, CD97, MGST1, EPHX1 and SOD2.
Because oxidative stress is considered one of the contributing factors in AMD, we also were interested in whether 0 ARPE-19 cells were more or less sensitive to oxidative stress than their ϩ counterparts. Figure 4 shows the results of a cell viability assay on cells treated with the oxidant tBH. These results show that the 0 ARPE-19 cells are much more sensitive to the oxidant than are the control cells, indicating that the 0 ARPE-19 cells are more sensitive to oxidative stress than their ϩ counterparts. Finally, because pigmentary changes due to clumping and migration of the RPE are characteristic of AMD and because of the observed changes in extracellular matrix and matrix metalloproteinase gene expression observed in this study, we were interested in whether we could demonstrate a change in invasive phenotype in our 0 cells. Figure 5 shows the result of a migration assay using solubulized basement membrane-coated Table 1 . Error bars, ϮSEM. Statistical significance was calculated from raw data normalized to cyclophilin A as the housekeeping gene. *P Յ 0.05; **P Յ 0.01; ***P Յ 0.001. 
DISCUSSION
The results show 0 ARPE-19 cells had a lower mitochondrial membrane potential than the ϩ ARPE-19 cells. It has been suggested that it is the reduced mitochondrial membrane potential in 0 cells and the resultant increase in intracellular free [Ca] 2ϩ that activates Ca 2ϩ -sensitive kinases, resulting in changes in nuclear gene expression. 22 Furthermore, 0 ARPE-19 cells upregulated several nuclear genes known to be associated with an aging RPE phenotype and/or with AMD. Some of the changes in nuclear gene expression in response to the loss of mitochondrial function are most likely an attempt to compensate for the energy deficit. This may explain the upregulation of genes for proteins involved in lipid transport such as APOE and VLDLR, and increased expression of the genes for the phagocytosis receptors ITGAV and ITGB5. This may be because the RPE, in contrast to the neural retina, apparently derives a large portion of its energy needs from mitochondrial fatty acid ␤-oxidation.
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Because mitochondrial fatty acid ␤-oxidation is normally linked to electron transport, nonmetabolized lipids would have to be excreted or they would accumulate intracellularly. This could account for the increase of esterified lipid shown to accumulate in basal linear deposits in AMD. The cell may also increase expression of VEGF and other angiogenic factors to attempt to compensate for low energy levels, in a fashion similar to tumor cells, which upregulate angiogenic cytokines as a response to hypoxia. This upregulation of VEGF in RPE cells would contribute to the choroidal neovascularization in advanced AMD. Other upregulated genes may be due to a state of chronic inflammatory response brought on by increased cellular oxidative stress. Increased oxidative stress was evidenced by the increased sensitivity of the 0 ARPE-19 cells to an oxidant challenge (Fig. 4) and by the increased expression of SOD2, EPHX1, and MGST1 (Fig. 3D) . Polymorphisms in SOD2 and EPHX1 have also been shown to be associated with AMD. 52 Although the effect of increased gene expression on protein translation was not measured, it is probably not coincidental that genes coding for proteins that have been identified as components of drusen were shown to be upregulated. This includes APOE, CLU, and FBLN. Vitronectin gene expression, the product of which is found in high concentrations in drusen, was shown to be markedly decreased in 0 ARPE-19 cells. However, it has been shown that vitronectin is abundantly expressed in the neural retina as well as the RPE, 56 and the vitronectin receptor genes ITGAV and ITGB5 were upregulated in 0 ARPE-19 cells. Therefore, vitronectin may be deposited in drusen as nonmetabolized receptor-vitronectin complexes. A more complete picture of the effect of mitochondrial dysfunction on cellular metabolism awaits further studies that should include measurements of changes in protein expression and enzyme activity.
In our study, 0 ARPE-19 cells had a more invasive phenotype that was the result of increased expression of inflammatory cytokines such as TGF␤ and of changes in ECM and MMP gene expression. These changes could explain observations of pigmentary changes in the maculas of patients with AMD and the observation that RPE cells have been identified as components of choroidal neovascular (CNV) membranes. 57 RPE cells in CNV membranes have also been reported to be immunoreactive for VEGF which correlates with the findings in the current study. Because other genes that are associated with an inflammatory response are also upregulated in 0 ARPE-19 cells, this VEGF immunoreactivity may indicate that these cells contribute to a chronic low level of inflammation in the retina and Bruch's membrane. There is ample evidence that drusen deposition in the RPE-choroid is associated with an inflammatory response. 58 The question is, what is the evidence of mitochondrial dysfunction in the aging human RPE cell? mtDNA deletions are clearly associated with human disease. This diverse group of diseases collectively termed mitochondrial myopathies include Kearns-Sayre syndrome (KSS); chronic progressive external ophthalmoplegia (CPEO); mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episode (MELAS); myoclonic epilepsy and ragged-red fibers (MERRF); and Leber hereditary optic neuropathy (LHON). These diseases are generally fatal, and it is the brain and muscles that are the tissues principally affected. However, it has also been reported that the retina, particularly the macular RPE, is also likely to be involved in these diseases. 59, 60 We have demonstrated that mitochondrial dysfunction is a normal consequence of aging in yeast. 21 The loss of mitochondrial function with age has been postulated to contribute to aging in higher eukaryotes as well, although definitive demonstration of widespread mitochondrial dysfunction with age has not been shown, perhaps because of the large number of mtDNA mutations known and the difficulty of quantifying all potential mtDNA mutations within a single sample. It has been demonstrated that mutations in mtDNA occur with aging in postmitotic tissues and can reach high levels in old individuals, 61 especially in the control region responsible for mtDNA replication and transcription. 62 The RPE mtDNA is particularly susceptible to oxidative damage. It is terminally differentiated, and damaged cells cannot be replaced by mitosis, whereas damage to the mtDNA can be propagated as the mitochondria in the cells divide. The RPE has a high metabolic demand and may produce high levels of oxidants in the mitochondria due to ␤ oxidation of fatty acids. We showed an increase in expression of SOD2 in our 0 ARPE-19 cells, suggesting increased superoxide production in the mitochondria. It has been reported that SOD2 activity increases with donor age in freshly isolated RPE cells, 63 and there is one report of an association of SOD2 polymorphism with exudative AMD. 52 Although there has been speculation as to how oxidative damage to mitochondria may lead to an RPE energy deficit or to RPE apoptotic or necrotic cell death, there has been no previous consideration of the response of nuclear gene expression to the mitochondrial dysfunction caused by oxidative damage to protein or DNA and how changes in nuclear gene expression may relate to clinical manifestations of AMD.
We postulate that accumulation of oxidative damage in mtDNA is the primary event leading to mitochondrial dysfunction and an inflammatory phenotype in the macula, but it is also possible that other cellular events could lead to drusen deposition that could precipitate an inflammatory response in the RPE or Bruch's membrane. The inflammatory response in turn could lead to the accumulation of toxic proteins such as ␤-amyloid which may be targeted to the mitochondria and also precipitate changes in nuclear gene expression. It has been recently reported that amyloid-P may be targeted to the mitochondria, resulting in mitochondrial dysfunction and loss of calcium homeostasis. 64 Because there is ample evidence of calcium deregulation in Alzheimer's disease, a similar scenario could be envisioned for the RPE-choroid, although the contribution of inflammatory protein deposition to mitochondrial dysfunction in the RPE must be demonstrated.
In Figure 6 we present a schematic representation of our hypothesis that the manifestations of AMD can be explained by damage to the mtDNA of the RPE, resulting in mitochondria containing dysfunctional electron transport chains. This dysfunction results in mitochondria with a lower mitochondrial membrane potential and increased superoxide production and in release of Ca 2ϩ into the cytoplasm. This in turn upregulates calcium-dependent kinases and nuclear transcription factors, which upregulate genes that aid in the survival of the RPE. However, although these changes in gene expression may contribute to RPE survival, they can also contribute to a pathologic state in the retina. FIGURE 6. Schematic representation of a hypothesis of how mitochondrial dysfunction could lead to a RPE phenotype, resulting in AMD. In this view, accumulated damage to mtDNA results in a defective electron transport chain due to an imbalance of transport chain components. This defect causes lower mitochondrial membrane potential (⌬ m ), increased superoxide production, and increased cytosolic [Ca 2ϩ ]. The resultant increase in Ca 2ϩ concentration activates calcium-dependent transcription factors that signal a nuclear response in an attempt to compensate for loss of energy production and to increase RPE cell viability. These gene expression changes contribute to some of the manifestations in AMD, such as RPE cell migration angiogenesis and lipid deposition. The excess superoxide production also contributes to an increased level of inflammation in the retina and Bruch's membrane.
